Sequelae of poliomyelitis

AB1_SEQULAE_POLIO

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — B91 Hospital discharge: ICD-9 — 138 Hospital discharge: ICD-8 — 04[4] Cause of death: ICD-10 — B91 Cause of death: ICD-9 — 138 Cause of death: ICD-8 — 04[4] 2 out of 7 registries used, show all original rules.	279
4. Check minimum number of events None	279
5. Include endpoints None	279
6. Filter based on genotype QC (FinnGen only)	279

Control definitions (FinnGen only)

Control exclude: AB1_SEQULEAE_OF_INFECTIONS_AND_PARASITES

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF5

NAME	AB1_SEQULAE_POLIO
CONTROL_EXCLUDE	AB1_SEQULEAE_OF_INFECTIONS_AND_PARASITES
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	B91
HD_ICD_9	138
HD_ICD_8	04[4]
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	B91
COD_ICD_9	138
COD_ICD_8	04[4]
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Sequelae of poliomyelitis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	3267	1689	1520
Only index persons	2365	1316	1049
Unadjusted period prevalence (%)
Whole population	0.05	0.05	0.04
Only index persons	0.04	0.05	0.04
Median age at first event (years)
Whole population	58.93	58.69	59.11
Only index persons	57.84	57.31	58.50

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	279	130	149
Unadjusted period prevalence (%)	0.06	0.04	0.07
Median age at first event (years)	59.05	57.03	60.81

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
252: Matched controls
2518

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

B91

ICD-10 Finland

Sequelae of poliomyelitis

13788.6

280.0

215

1380A

ICD-9 Finland

Late effects of acute poliomyelitis[SEQUELAE POLIOMYELITIDIS]

+∞

73.6

04499

ICD-8 Finland

Late effects of actue poliomyelitis

+∞

50.8

N70

ICPC

Poliomyelitis

+∞

45.2

L28

ICPC

Limited function/disability (L)

3.5

14.9

292

SPAT1229

SPAT

Assessment of need for aid

4.2

12.1

138

A28

ICPC

Limited function/disability NOS

2.8

9.8

309

M89.6

ICD-10 Finland

Osteopathy after poliomyelitis

+∞

9.4

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

6.8

8.7

N18

ICPC

Paralysis/weakness

9.9

7.9

S72.4

ICD-10 Finland

Fracture of lower end of femur

16.3

7.3

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

4.1

6.5

M41.9

ICD-10 Finland

Scoliosis, unspecified

11.4

6.4

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.4

6.2

248

X59

ICD-10 Finland

Exposure to unspecified factor

2.5

6.0

221

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3024561) Albumin [Mass/volume] in Serum or Plasma

139

1037

1.68

4.35

5.7

4.4

33.3

34.9

g/l

2.13

126

962

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

123

901

1.65

4.05

2.5

2.2

79.9

78.9

nmol/l

0.13

107

780

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

283

1.89

3.67

5.0

4.2

20.5

45.3

ug/l

0.36

247

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

472

1.64

3.06

3.5

3.8

183.7

157.3

ng/l

0.08

409

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

135

2.11

3.02

9.0

8.9

—

(3000991) Gas panel - Venous blood

201

1.91

2.99

7.6

7.5

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

137

1097

1.49

2.73

7.0

5.8

1.2

mmol/l

0.16

124

980

(42870588) Differential panel, method unspecified - Blood

709

1.52

2.65

5.1

5.6

—

(3003396) Base excess in Arterial blood by calculation

304

1.70

2.65

6.6

6.8

2.1

1.1

mmol/l

1.03

244

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

148

1210

1.48

2.63

9.0

6.5

1.2

mmol/l

0.56

126

1021

(3035637) Corticotropin [Mass/volume] in Plasma

3.89

2.48

1.6

1.5

—

(36660697) Celiac disease serology panel - Serum

132

1.98

2.45

1.2

—

(3027801) Oxygen [Partial pressure] in Arterial blood

307

1.64

2.31

6.8

6.7

11.8

11.6

kpa

0.09

295

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

307

1.64

2.31

6.7

5.3

5.0

kpa

1.96

294

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

5.63

2.22

1.0

—

(3052851) Hemolysis interference index of Serum or Plasma

2.17

2.9

3.9

—

(40758558) Short blood count panel - Blood

538

1.48

2.11

7.3

6.8

—

(3023368) Bacteria identified in Blood by Culture

720

1.44

2.09

3.9

4.2

—

(3021960) Folate [Moles/volume] in Serum or Plasma

595

1.46

2.05

1.6

17.9

20.3

nmol/l

1.06

491

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

135

1.85

1.98

5.8

6.1

25.7

24.6

mmol/l

0.89

135

(3002032) Base excess in Venous blood by calculation

223

1.65

1.91

3.9

3.4

2.5

2.0

mmol/l

0.47

175

(40760892) CBC W Ordered Manual Differential panel - Blood

406

0.58

1.87

5.6

5.3

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

177

1.71

1.85

4.2

3.2

119.1

81.2

ng/l

0.84

155

(3051593) INR in Capillary blood by Coagulation assay

4.22

1.83

4.2

18.0

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

122

1013

1.36

1.76

2.2

2.0

90.8

92.0

pmol/l

0.09

514

(3018418) pH of Serum or Plasma

740

1.39

1.75

5.2

4.1

7.4

0.18

133

(3004789) Transferrin [Mass/volume] in Serum or Plasma

338

1.51

1.73

2.5

2.2

2.3

g/l

0.14

307

(3024928) Oxygen saturation in Venous blood

2.34

1.73

2.1

2.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

0.00

1.72

0.0

1.5

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

150

1.73

1.70

2.6

3.0

2.2

2.0

mmol/l

0.14

114

(3051611) Lipemic interference index of Serum or Plasma

2.63

1.67

2.4

3.5

—

(3012544) pH of Venous blood

232

1.58

1.64

4.0

3.5

—

(3018095) Leukocytes [#/volume] in Urine

102

841

1.34

1.50

5.1

4.1

827.2

107.1

e6/l

0.55

618

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

490

1.40

1.50

4.7

3.0

2.5

mmol/l

0.75

426

(3032080) INR in Blood by Coagulation assay

120

1014

1.32

1.48

7.2

9.7

1.3

inr

0.17

281

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

2.27

1.48

1.2

—

(3000492) Spirometry study

165

0.47

1.40

1.6

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

606

1.35

1.38

2.6

2.0

2.8

3.3

mg/l

1.19

520

(3044290) Cell count panel - Cerebral spinal fluid

2.23

1.38

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

0.00

1.35

0.0

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

2.17

1.35

1.0

1.5

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

2.17

1.35

1.0

1.5

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

139

1210

1.30

1.35

7.3

6.5

10.8

11.7

umol/l

0.57

131

1145

(1616796) Gas panel - Central venous blood

2.13

1.31

2.8

3.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

2.04

1.29

1.4

1.9

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

2.32

1.28

1.0

1.3

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

404

1.39

1.27

4.2

3.2

3.4

1.9

e6/l

0.33

231

(3015377) Calcium [Moles/volume] in Serum or Plasma

804

1.30

1.23

4.7

3.2

2.3

2.4

mmol/l

0.15

688

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

2.66

1.22

1.0

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

189

1726

1.29

1.21

8.4

7.8

82.9

79.0

u/l

0.41

175

1607

(3002256) Pathology report gross observation

267

1.44

1.20

1.2

1.3

—

(3022096) Basophils/100 leukocytes in Blood

110

940

1.28

1.20

5.2

5.7

0.6

0.11

103

870

(3002030) Lymphocytes/100 leukocytes in Blood

115

989

1.28

1.19

6.0

5.9

26.2

26.0

0.06

105

908

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

2.34

1.19

1.2

2.4

20.8

76.7

u/ml

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

138

1544

0.79

1.16

3.7

15.5

15.1

pmol/l

1.13

126

1343

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

1.14

0.0

1.6

—

(3039443) Prostate specific Ag panel - Serum or Plasma

0.00

1.14

0.0

1.5

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

2.37

1.13

1.0

1.2

—

(3006504) Eosinophils/100 leukocytes in Blood

112

966

1.27

1.12

5.9

5.7

3.1

2.8

0.51

105

891

(1761868) Lipid panel - Serum or Plasma

569

0.73

1.11

3.2

3.3

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

325

1.38

1.09

2.8

2.2

20.8

21.9

0.23

277

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1.69

1.09

2.4

2.0

394.1

336.3

ug/l

0.12

(3019069) Monocytes/100 leukocytes in Blood

112

971

1.26

1.06

7.0

6.0

8.6

8.8

0.26

104

902

(3002582) Erythrocytes [#/volume] in Urine

752

1.27

1.05

4.7

3.5

67.8

148.6

e6/l

0.40

581

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

400

1.34

1.04

1.3

1.2

11.2

1.0

u/ml

—

105

(3037467) Urinalysis macro (dipstick) panel - Urine

170

1549

1.25

1.03

5.1

4.7

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1.75

1.00

2.0

2.1

0.3

u/ml

—

(3021788) Differential panel - Synovial fluid

2.03

1.00

1.3

1.2

—

(3009542) Hematocrit [Volume Fraction] of Blood

189

1746

1.26

0.99

22.3

18.6

37.4

38.6

0.77

115

1088

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

421

1.32

0.99

3.9

2.9

0.8

1.0

e6/l

0.29

246

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.98

0.0

1.7

—

(3022217) INR in Platelet poor plasma by Coagulation assay

368

1.33

0.97

15.4

25.3

1.5

1.3

inr

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

414

1.31

0.96

2.0

1.9

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.95

0.0

1.6

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

150

1355

1.23

0.95

5.8

4.9

7.1

6.9

mmol/l

0.60

140

1269

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

2.25

0.94

1.7

1.4

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

696

1.25

0.92

2.7

2.3

58.7

58.4

u/l

0.02

646

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

2.17

0.92

1.0

1.4

1.1

0.5

nmol/l

—

(3044927) Protein electrophoresis panel - Urine

2.17

0.92

1.3

1.1

—

(36304419) Bacteria [Presence] in Urine

649

1.26

0.92

4.1

3.3

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1.68

0.89

1.3

—

(3007164) IgA [Mass/volume] in Serum or Plasma

373

1.31

0.89

1.5

2.5

2.7

g/l

0.19

204

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

179

1.44

0.87

2.0

1.6

—

(4010399)

162

1.46

0.87

1.3

1.4

—

(3021901) Oxygen saturation in Capillary blood

1.84

0.86

2.1

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1.70

0.86

1.5

1.7

—

132.0

—

(3018010) Neutrophils/100 leukocytes in Blood

111

981

1.22

0.85

5.8

5.6

58.4

58.5

0.01

102

910

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

1.96

0.85

1.0

—

(3026008) Bacteria identified in Urine by Culture

789

1.23

0.84

3.8

3.5

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

292

0.70

0.83

8.7

7.4

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

1.89

0.82

1.0

1.4

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

1.89

0.82

2.8

3.2

58.8

60.4

—

(3019060) Gas panel - Arterial blood

182

1.41

0.81

5.2

4.4

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

279

1.33

0.81

2.0

1.9

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

668

1.23

0.81

3.4

39.6

32.0

u/l

0.84

638

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

244

1.35

0.80

3.5

3.8

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

584

1.24

0.79

1.4

1.6

1.3

mmol/l

0.09

481

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

0.50

0.79

1.0

2.5

3.8

4.3

pmol/l

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.79

0.0

1.8

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.00

0.79

0.0

1.8

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.79

0.0

1.1

—

4.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.79

0.0

1.8

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1.69

0.79

1.9

1.1

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

827

0.81

0.79

4.4

4.5

—

(3019309) Folate [Moles/volume] in Red Blood Cells

520

1.25

0.77

2.0

1.7

1183.5

1162.8

nmol/l

0.07

389

(3042936) Bacteria identified in Isolate by Culture

354

1.29

0.77

2.2

1.9

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.76

0.0

1.3

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

2.10

0.75

1.0

1.4

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1.86

0.74

1.0

1.9

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

1.86

0.74

1.1

1.2

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

847

1.20

0.74

3.0

2.5

134.9

143.7

ug/l

0.15

759

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1.63

0.73

1.1

564.9

498.2

mg/l

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

182

1932

0.83

0.72

3.9

4.3

1.3

1.2

mmol/l

0.24

163

1711

(40760888) Immunoglobulin light chains.free panel - Serum

1.60

0.72

5.0

6.6

—

(3003327) Ova and parasites identified in Stool by Light microscopy

1.60

0.72

2.4

1.5

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

1.94

0.71

1.2

1.1

—

(3044941) Cell count panel - Synovial fluid

1.94

0.71

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

1.94

0.71

1.0

1.4

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

115

1036

1.19

0.70

3.6

4.3

—

(3037121) Protein [Mass/volume] in Urine

1.58

0.69

5.6

3.3

0.2

g/l

—

(3044640) Blood type and Crossmatch panel - Blood

736

1.20

0.69

2.3

2.6

—

(3022313) Gas panel - Capillary blood

119

1.46

0.68

3.1

3.0

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1.80

0.66

1.8

1.4

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

1.80

0.66

2.0

1.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1.80

0.66

1.2

1.1

152.0

388.5

u/ml

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1.74

0.64

1.2

—

(3000850) Epithelial cells [#/volume] in Urine

522

1.22

0.64

3.3

2.7

5.0

4.5

e6/l

0.17

460

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

152

0.65

0.63

1.5

1.4

—

(3013290) Carbon dioxide [Partial pressure] in Blood

1.65

0.62

3.0

4.0

5.3

5.1

kpa

—

(3027315) Oxygen [Partial pressure] in Blood

1.65

0.62

3.0

4.0

8.9

7.9

kpa

—

(3013512) EKG study

736

0.83

0.62

3.9

4.2

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

282

1.28

0.62

1.9

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

1.68

0.61

3.0

2.4

3.8

5.3

e9/l

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

183

1930

0.85

0.61

4.7

4.6

1.7

2.0

mu/l

2.27

162

1686

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1.52

0.61

4.1

5.4

—

2.9

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.60

0.0

1.3

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1.47

0.60

3.1

3.4

25.4

mmol/l

0.05

(3007853) Bacteria identified in Skin by Aerobe culture

247

1.29

0.60

2.3

1.7

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.59

0.0

1.1

—

1.7

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

0.00

0.59

0.0

1.2

—

7.5

—

(3025941) Bacteria identified in Stool by Culture

111

0.62

0.59

1.1

1.4

—

(3030467) Casts [#/volume] in Urine by Automated count

689

1.18

0.59

4.2

3.4

0.3

0.6

e6/l

0.73

517

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.58

0.0

1.0

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

150

1.36

0.57

1.6

1.7

—

(3002385) Erythrocyte distribution width [Ratio]

178

1681

1.16

0.56

25.4

21.1

14.2

13.9

1.44

172

1647

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

315

0.77

0.55

5.1

4.7

28.6

32.1

1.26

197

(3017143) Hepatitis C virus Ab [Presence] in Serum

160

1.34

0.55

1.5

1.4

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1.52

0.55

1.2

—

4.4

—

(3009508) Creatinine [Moles/volume] in Urine

713

1.17

0.54

4.0

3.1

6.5

7.1

mmol/l

0.85

578

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

217

2085

1.18

0.53

20.8

17.0

28.7

26.3

mg/l

0.51

183

1698

(3019225) pH of Specimen

243

1.26

0.52

6.0

3.9

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

1.51

0.52

3.5

2.9

16.3

34.0

u/ml

—

(3019230) Fractional oxyhemoglobin in Venous blood

1.51

0.52

1.0

1.9

46.8

59.2

—

(3022621) pH of Urine by Test strip

163

1.31

0.50

3.3

3.2

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

181

1.30

0.50

1.4

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

884

1.15

0.49

4.5

3.4

—

(40768804) Tissue Pathology biopsy report

856

1.15

0.48

2.1

2.2

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1.50

0.48

1.9

1.2

—

(3001604) Monocytes [#/volume] in Blood

112

1034

1.14

0.47

5.8

5.5

0.6

e9/l

0.25

891

(3013115) Eosinophils [#/volume] in Blood

116

1074

1.14

0.46

6.1

5.7

0.2

e9/l

0.08

939

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1.44

0.46

1.4

1.3

—

(3026493) Urate [Moles/volume] in Serum or Plasma

582

0.85

0.46

2.9

3.0

8984.7

6325.3

umol/l

0.12

476

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

200

2076

0.87

0.45

4.9

5.1

6.2

6.1

mmol/l

0.12

178

1849

(3000330) Specific gravity of Urine by Test strip

140

0.70

0.44

2.1

4.5

—

(21494434) Karyotype in Bone marrow

1.62

0.43

1.2

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

1.42

0.42

3.4

3.1

0.9

nmol/l

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

1.57

0.42

1.8

1.2

4.2

8.8

u/l

—

(3006315) Basophils [#/volume] in Blood

112

1040

1.13

0.42

5.8

5.5

0.0

e9/l

0.19

899

(40768800) Prostate Pathology biopsy report

1.39

0.42

1.0

1.1

—

(44806420)

0.00

0.41

0.0

2.2

—

(3024263) Appearance of Synovial fluid

0.00

0.41

0.0

1.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.4

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

0.00

0.41

0.0

3.4

—

23.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

0.00

0.41

0.0

1.2

—

(4306422)

0.00

0.41

0.0

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

0.00

0.41

0.0

1.2

—

(3010421) pH of Blood

1.34

0.40

3.1

3.6

7.4

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.40

0.0

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.40

0.0

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.40

0.0

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.40

0.0

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.40

0.0

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

0.00

0.40

0.0

1.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1.42

0.40

1.6

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

0.00

0.39

0.0

4.0

—

(3023520) Reticulocytes [#/volume] in Blood

226

1.22

0.37

3.0

2.9

67.6

68.6

e9/l

0.04

180

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1.30

0.37

1.1

—

(3029937) Albumin [Presence] in Urine by Test strip

591

0.87

0.36

4.7

4.4

0.0

estimate

0.00

196

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

725

0.88

0.36

3.7

4.6

24.2

21.3

0.80

382

(3027945) Reticulocytes/100 erythrocytes in Blood

312

1.18

0.35

2.3

2.8

1.7

1.8

0.38

278

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

193

1995

0.89

0.34

4.3

4.8

1.4

1.5

mmol/l

0.30

174

1777

(3049717) Cytology report of Urine Cyto stain

118

1.29

0.34

3.5

2.8

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

129

1220

1.11

0.34

9.7

9.3

4.3

4.2

e9/l

0.07

106

1067

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1.34

0.34

1.5

1.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1.34

0.34

1.0

1.3

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

201

1.21

0.33

2.8

1.9

363.2

359.4

nmol/l

0.03

186

(3021589) Normoblasts [#/volume] in Blood

100

934

1.11

0.33

9.5

10.3

0.0

e9/l

0.59

774

(3003694) ABO and Rh group [Type] in Blood

518

1.13

0.30

1.3

—

(3004588) Protein electrophoresis panel - Serum or Plasma

186

1.20

0.29

4.2

3.0

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

196

2016

0.91

0.28

4.4

4.8

4.5

mmol/l

0.11

178

1808

(3013707) Erythrocyte sedimentation rate by Westergren method

166

1599

1.09

0.28

4.2

4.4

16.5

14.2

mm/h

1.07

159

1450

(3019198) Lymphocytes [#/volume] in Blood

112

1060

1.09

0.28

5.8

5.6

1.6

1.9

e9/l

1.15

938

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

203

2084

0.90

0.28

4.9

5.5

2.6

mmol/l

0.21

182

1857

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1.22

0.27

1.3

1.5

186.5

268.9

ug/g

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

513

1.11

0.27

1.9

1.8

447.0

435.7

pmol/l

0.11

425

(46235355) HIV 1 and 2 tests - Meaningful Use set

197

1.18

0.27

1.6

1.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1.27

0.26

2.0

1.6

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

516

0.89

0.26

2.6

3.2

1.0

0.8

ug/l

0.65

374

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

127

0.78

0.26

2.3

2.5

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

505

1.11

0.25

3.7

3.9

—

(40768797) Stomach Pathology biopsy report

303

1.14

0.25

1.3

1.2

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

124

1188

1.08

0.23

3.3

53.7

54.5

u/l

0.04

111

1083

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

899

0.92

0.23

4.8

5.3

3.0

ug/l

0.34

788

(3005322) IgE [Units/volume] in Serum or Plasma

0.75

0.23

1.1

1.2

54.6

204.6

u/ml

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

0.75

0.23

1.6

3.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

188

0.84

0.22

1.4

1.6

—

(3043410) Blood group antigens tested for on Red Blood Cells

0.00

0.21

0.0

1.3

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

0.00

0.21

0.0

7.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

0.00

0.21

0.0

1.3

—

(4211845)

0.00

0.21

0.0

5.8

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

4.7

—

(3008536) Aspergillus sp Ab [Presence] in Serum

0.00

0.21

0.0

1.4

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

0.00

0.21

0.0

1.1

—

8.4

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

3.4

—

(21491868) Cryoglobulin [Mass/volume] in Serum

0.00

0.21

0.0

1.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.9

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.3

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.9

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.3

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1.17

0.21

1.0

1.4

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

202

1.15

0.21

1.3

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.9

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

0.00

0.21

0.0

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.9

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

0.00

0.20

0.0

1.1

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

0.00

0.20

0.0

1.1

—

(3028433) Virus identified in Specimen by Culture

0.00

0.20

0.0

1.1

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

115

0.78

0.20

1.7

1.3

—

54.9

—

(3022145) Colonoscopy Study observation

259

0.88

0.19

1.8

1.3

—

(3026782) Osmolality of Urine

504

1.09

0.19

3.0

3.1

545.2

559.9

mosm/kgh2o

0.25

427

(3041096) Erythrocytes [Presence] in Urine by Automated

577

0.92

0.18

3.3

4.1

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

564

1.08

0.18

2.5

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

309

0.90

0.18

1.1

1.3

14.0

48.9

iu/ml

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1.13

0.17

1.1

1.3

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

467

1.09

0.17

1.5

1.7

1.1

1.5

mg/l

0.92

371

(3037756) Immunofixation for Serum or Plasma

1.11

0.17

4.1

1.7

—

(3035350) Ketones [Presence] in Urine by Test strip

110

1060

1.06

0.16

3.5

4.2

0.0

estimate

0.00

207

(3000494) Fungus identified in Specimen by Culture

266

0.89

0.16

1.8

1.4

—

(40761535) Cells panel - Urine sediment

203

0.88

0.16

3.1

3.5

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

735

1.07

0.15

2.6

2.1

524.9

239.0

u/l

0.40

684

(3013139) Helicobacter pylori Ag [Presence] in Stool

121

1.17

0.15

1.1

1.3

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

197

2005

0.94

0.15

6.3

6.6

40.4

40.9

mmol/mol

0.27

176

1832

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.20

0.14

1.2

1.0

—

(40768443) Skin Pathology biopsy report

0.80

0.14

1.4

1.3

—

(3021601) Nitrite [Presence] in Urine by Test strip

110

1066

1.05

0.13

4.7

5.7

0.0

estimate

0.00

203

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

105

1.15

0.11

2.2

1.8

—

(3044889) 12 lead EKG panel

157

1541

1.04

0.10

3.9

4.3

—

(4035726)

213

1.09

0.09

1.7

1.3

—

(3048689) Calprotectin [Mass/mass] in Stool

217

0.92

0.09

2.8

2.0

262.1

149.7

ug/g

0.48

174

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

985

0.96

0.09

3.3

4.2

60.8

47.5

ng/l

0.18

771

(3014051) Protein [Presence] in Urine by Test strip

1.05

0.08

2.2

2.4

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1.04

0.08

1.3

1.5

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

0.82

0.08

1.8

1.6

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

0.79

0.08

1.0

1.2

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

0.77

0.08

1.0

1.7

—

(3020682) Albumin/Creatinine [Ratio] in Urine

758

1.04

0.08

5.0

3.9

22.0

9.0

mg/mmol

0.59

470

(3020961) Endomysium IgA Ab [Titer] in Serum

0.83

0.07

1.0

1.1

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

122

0.90

0.07

1.5

2.4

1.3

1.1

0.33

122

(3045414) Leukocytes [Presence] in Urine

1.05

0.07

1.8

2.0

—

(3012516) Albumin [Mass/volume] in Urine

712

1.03

0.06

4.2

3.2

110.6

145.2

mg/l

0.13

461

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

109

1.11

0.06

2.0

2.2

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

225

2234

1.04

0.06

23.9

19.8

139.0

139.6

mmol/l

1.98

218

2168

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

197

1987

0.97

0.05

21.7

16.2

82.7

73.1

ml/min/173m2

6.24

155

1627

(3023103) Potassium [Moles/volume] in Serum or Plasma

225

2237

1.03

0.04

24.4

19.9

4.0

mmol/l

1.67

218

2170

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

170

1.06

0.04

4.4

3.3

68.3

58.2

ml/min/173m2

—

(3037522) Nuclear Ab [Titer] in Serum

240

0.95

0.03

1.3

288.0

534.3

titre

—

(3009261) Glucose [Presence] in Urine by Test strip

109

1078

1.02

0.03

3.6

4.3

0.0

estimate

0.00

193

(40761511) CBC panel - Blood by Automated count

216

2150

1.02

0.02

17.1

16.0

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

940

1.02

0.02

2.6

2.2

—

(3007461) Platelets [#/volume] in Blood

228

2271

1.02

0.02

28.0

24.7

255.5

240.9

e9/l

2.26

216

2206

(3024731) MCV [Entitic volume]

228

2271

1.02

0.02

28.4

24.7

91.3

91.8

0.67

220

2232

(3035941) MCH [Entitic mass]

228

2271

1.02

0.02

28.4

24.6

30.1

30.4

1.43

220

2232

(3026361) Erythrocytes [#/volume] in Blood

228

2272

1.02

0.01

28.5

24.7

4.3

4.4

e12/l

1.57

216

2192

(3010813) Leukocytes [#/volume] in Blood

228

2272

1.02

0.01

28.4

24.7

7.1

6.9

e9/l

0.42

217

2192

(3000963) Hemoglobin [Mass/volume] in Blood

228

2272

1.02

0.01

28.5

24.9

129.3

133.2

g/l

3.21

220

2229

(3020564) Creatinine [Moles/volume] in Serum or Plasma

222

2214

1.01

0.00

24.4

20.3

72.1

81.6

umol/l

2.98

222

2214

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

220

2206

0.99

0.00

11.9

11.4

27.2

24.2

u/l

1.18

211

2106

(40761536) Microorganisms panel - Urine sediment

179

1.01

0.00

4.6

4.0

—

(3019150) Specific gravity of Urine by Refractometry

473

0.99

0.00

4.5

4.7

1.0

kg/l

0.46

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

204

0.98

0.00

1.4

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

835

0.99

0.00

2.3

3.1

1270.6

1635.3

ng/l

0.36

723

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

0.89

0.00

2.6

0.0

g/l

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

0.96

0.00

1.2

—

2.6

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.00

0.0

1.6

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

0.00

0.0

1.0

—

124.0

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

0.00

0.0

1.4

—

(40757373) Influenza virus identified in Isolate

0.00

0.0

1.4

—

(3037556) Urate [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

0.00

0.0

1.0

—

146.4

—

(3051101) Glucose [Moles/volume] in Cord blood

0.00

0.0

3.4

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

0.00

0.0

1.3

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.00

0.0

1.3

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

0.97

0.00

2.4

2.5

0.0

g/l

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

0.88

0.00

1.3

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

0.00

0.0

4.4

—

51.8

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

0.00

0.0

1.5

—

(3020891) Body temperature

1.00

0.00

2.3

4.8

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

0.00

0.0

1.3

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

0.00

0.0

1.3

—

(3035933) Granulocytes/100 leukocytes in Blood

0.00

0.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

0.00

0.0

1.3

—

(3014891) Appearance of Pleural fluid

0.00

0.0

1.3

—

(3006462) Nitrate [Presence] in Urine

0.00

0.0

6.3

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

0.0

1.9

—

109.9

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3020650) Glucose [Presence] in Urine

0.00

0.0

1.2

—

(3003129) Base excess in Capillary blood by calculation

0.00

0.0

1.1

—

3.8

—

(3015183) Erythrocyte sedimentation rate

0.00

0.0

1.5

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

0.00

0.0

1.3

—

1055.3

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

0.00

0.0

1.0

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.7

—

23.1

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

0.88

0.00

2.6

0.0

g/l

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.00

0.0

1.2

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.00

0.0

1.0

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

0.00

0.0

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

0.0

1.5

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.0

1.0

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

0.0

1.4

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

0.00

0.0

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

0.00

0.0

1.0

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

0.00

0.0

1.7

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

0.00

0.0

1.5

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

0.00

0.0

1.6

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.0

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.00

0.0

1.3

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

120

1.00

0.00

1.6

1.3

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

0.00

0.0

3.2

—

1.1

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1.00

0.00

2.3

2.6

1.9

0.8

g/l

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

0.00

0.0

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

0.00

0.0

1.0

—

(4015189)

0.00

0.0

3.4

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

0.00

0.0

1.0

—

(40758292) HTLV I+II Ab panel - Serum

0.00

0.0

1.8

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

0.00

0.0

1.0

—

20.8

—

Mortality – FinRegistry

↥

Association

Association between endpoint AB1_SEQULAE_POLIO and mortality.

Females

Parameter	HR [95% CI]	p-value
AB1_SEQULAE_POLIO	1.391 [1.15, 1.68]	< 0.001
Birth year	0.995 [0.99, 1.0]	0.261

During the follow-up period (1.1.1998 — 31.12.2019), 218 out of 652 females with AB1_SEQULAE_POLIO died.

Males

Parameter	HR [95% CI]	p-value
AB1_SEQULAE_POLIO	1.694 [1.4, 2.05]	< 0.001
Birth year	0.988 [0.98, 1.0]	0.01

During the follow-up period (1.1.1998 — 31.12.2019), 273 out of 623 males with AB1_SEQULAE_POLIO died.

Mortality risk

Mortality risk for people of age

years, who have AB1_SEQULAE_POLIO.

N-year risk	Females	Males
1	0.116%	0.295%
5	0.895%	1.986%
10	2.244%	4.869%
15	4.346%	9.197%
20	7.669%	15.654%

Relationships between endpoints

↥

Index endpoint: AB1_SEQULAE_POLIO – Sequelae of poliomyelitis

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Sequelae of poliomyelitis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints